As of 3:54pm ET
| -0.29 / -0.60%|
The 16 analysts offering 12-month price forecasts for Novozymes A/S have a median target of 43.77, with a high estimate of 54.68 and a low estimate of 36.90. The median estimate represents a -8.97% decrease from the last price of 48.08.
The current consensus among 16 polled investment analysts is to Hold stock in Novozymes A/S. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.